Cell Therapy Processing Market Size, Share, Growth, Trends, Production, Consumption, Revenue and Forecast 2020 to 2027

Table of Content

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018

3.3. Porter’s five force analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the incidence of cardiovascular diseases
3.4.1.2. Rise in the demand for chimeric antigen receptor (CAR) t cell therapy
3.4.1.3. Increase in the development of stem cell therapy approaches

3.4.2. Restraint

3.4.2.1. Poor demand in under developed countries

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets

3.4.4. Impact analysis

CHAPTER 4: CELL THERAPY PROCESSING MARKET, BY OFFERING TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Products

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Services

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Software

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

CHAPTER 5: GLOBAL CELL THERAPY PROCESSING MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Cardiovascular diseases

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Bone Repair

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Neurological Disorders

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Skeletal Muscle Repair

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Cancer

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

5.7. Other Applications

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

CHAPTER 6: CELL THERAPY PROCESSING MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. North America CELL THERAPY PROCESSING market, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. market size and forecast, by offering type
6.2.2.1.2. U.S. market size and forecast, by application

6.2.2.2. Canada

6.2.2.2.1. Canada market size and forecast, by OFFERING TYPE
6.2.2.2.2. Canada market size and forecast, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico market size and forecast, by OFFERING TYPE
6.2.2.3.2. Mexico market size and forecast, by application

6.2.3. North America market size and forecast, by offering type
6.2.4. North America market size and forecast, by application

6.3. Europe

6.3.1. Key market trends and opportunities
6.3.2. Europe cell therapy processing market, by country

6.3.2.1. Germany

6.3.2.1.1. Germany market size and forecast, by OFFERING TYPE
6.3.2.1.2. Germany market size and forecast, by application

6.3.2.2. France

6.3.2.2.1. France market size and forecast, by OFFERING TYPE
6.3.2.2.2. France market size and forecast, by application

6.3.2.3. UK

6.3.2.3.1. UK market size and forecast, by OFFERING TYPE
6.3.2.3.2. UK market size and forecast, by application

6.3.2.4. Italy

6.3.2.4.1. Italy market size and forecast, by OFFERING TYPE
6.3.2.4.2. Italy market size and forecast, by application

6.3.2.5. Spain

6.3.2.5.1. Spain market size and forecast, by OFFERING TYPE
6.3.2.5.2. Spain market size and forecast, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe market size and forecast, by OFFERING TYPE
6.3.2.6.2. Rest of Europe market size and forecast, by application

6.3.3. Europe market size and forecast, by OFFERING TYPE
6.3.4. Europe market size and forecast, by application

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific CELL THERAPY PROCESSING market, by country

6.4.2.1. Japan

6.4.2.1.1. Japan market size and forecast, by offering type
6.4.2.1.2. Japan market size and forecast, by application

6.4.2.2. China

6.4.2.2.1. China market size and forecast, by offering type
6.4.2.2.2. China market size and forecast, by application

6.4.2.3. India

6.4.2.3.1. India market size and forecast, by OFFERING TYPE
6.4.2.3.2. India market size and forecast, by application

6.4.2.4. Rest of Asia-Pacific

6.4.2.4.1. Rest of Asia-Pacific market size and forecast, by OFFERING TYPE
6.4.2.4.2. Rest of Asia-Pacific market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by offering type
6.4.4. Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA CELL THERAPY PROCESSING market, by country

6.5.2.1. Latin America

6.5.2.1.1. Latin America market size and forecast, by OFFERING TYPE
6.5.2.1.2. Latin America market size and forecast, by application

6.5.2.2. Middle East

6.5.2.2.1. Middle East market size and forecast, by OFFERING TYPE
6.5.2.2.2. Middle East market size and forecast, by application

6.5.2.3. Africa

6.5.2.3.1. Africa market size and forecast, by offering type
6.5.2.3.2. Africa market size and forecast, by application

6.5.3. LAMEA market size and forecast, by OFFERING TYPE
6.5.4. LAMEA market size and forecast, by application

CHAPTER 7: COMPANY PROFILES

7.1. Cell Therapies Pty Ltd

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio

7.2. INVITRX INC.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio

7.3. LONZA LTD

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance

7.4. Merck & Co., Inc. (FloDesign Sonics)

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance

7.5. NantWorks, LLC

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio

7.6. Neurogeneration, Inc.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio

7.7. Novartis AG

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance

7.8. Plasticell Ltd.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Key strategic moves and developments

7.9. REGENEUS LTD

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. StemGenex, Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio